These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 10741408

  • 1. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis.
    Zang YC, Hong J, Tejada-Simon MV, Li S, Rivera VM, Killian JM, Zhang JZ.
    Eur J Immunol; 2000 Mar; 30(3):908-13. PubMed ID: 10741408
    [Abstract] [Full Text] [Related]

  • 2. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G, Denzer U, Lohse A, Raus J, Stinissen P.
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [Abstract] [Full Text] [Related]

  • 3. In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination.
    Zhang J, Vandevyver C, Stinissen P, Raus J.
    J Immunol; 1995 Dec 15; 155(12):5868-77. PubMed ID: 7499877
    [Abstract] [Full Text] [Related]

  • 4. T-cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy.
    Zhang J.
    Crit Rev Immunol; 2001 Dec 15; 21(1-3):41-55. PubMed ID: 11642613
    [Abstract] [Full Text] [Related]

  • 5. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
    Hermans G, Stinissen P, Hauben L, Van den Berg-Loonen E, Raus J, Zhang J.
    Ann Neurol; 1997 Jul 15; 42(1):18-27. PubMed ID: 9225681
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.
    Sun W, Popat U, Hutton G, Zang YC, Krance R, Carrum G, Land GA, Heslop H, Brenner M, Zhang JZ.
    Brain; 2004 May 15; 127(Pt 5):996-1008. PubMed ID: 14985264
    [Abstract] [Full Text] [Related]

  • 7. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P, Totaro R, Contasta I, Berghella AM, Carolei A, Adorno D.
    Neuroimmunomodulation; 2005 May 15; 12(4):220-34. PubMed ID: 15990453
    [Abstract] [Full Text] [Related]

  • 8. T cell vaccination in multiple sclerosis: hopes and facts.
    Zhang J, Raus J.
    Acta Neurol Belg; 1994 May 15; 94(2):112-5. PubMed ID: 7518632
    [Abstract] [Full Text] [Related]

  • 9. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T.
    Brain; 2004 Sep 15; 127(Pt 9):1917-27. PubMed ID: 15229129
    [Abstract] [Full Text] [Related]

  • 10. MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders.
    Mannie MD, Norris MS.
    Cell Immunol; 2001 Aug 25; 212(1):51-62. PubMed ID: 11716529
    [Abstract] [Full Text] [Related]

  • 11. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P, Raus J.
    Acta Neurol Belg; 1999 Mar 25; 99(1):65-9. PubMed ID: 10218096
    [Abstract] [Full Text] [Related]

  • 12. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.
    Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ.
    Ann Neurol; 2003 Feb 25; 53(2):189-97. PubMed ID: 12557285
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human T lymphocyte response to myelin basic protein: selection of T lymphocyte lines from MBP-responsive donors.
    Vandenbark AA, Chou YK, Bourdette D, Whitham R, Chilgren J, Chou CH, Konat G, Hashim G, Vainiene M, Offner H.
    J Neurosci Res; 1989 May 25; 23(1):21-30. PubMed ID: 2473214
    [Abstract] [Full Text] [Related]

  • 15. T-cell vaccination in multiple sclerosis.
    Achiron A, Mandel M.
    Autoimmun Rev; 2004 Jan 25; 3(1):25-32. PubMed ID: 14871646
    [Abstract] [Full Text] [Related]

  • 16. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis.
    Burns J, Bartholomew B, Lobo S.
    Ann Neurol; 1999 Jan 25; 45(1):33-9. PubMed ID: 9894874
    [Abstract] [Full Text] [Related]

  • 17. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
    Kumar M, Putzki N, Limmroth V, Remus R, Lindemann M, Knop D, Mueller N, Hardt C, Kreuzfelder E, Grosse-Wilde H.
    J Neuroimmunol; 2006 Nov 25; 180(1-2):178-84. PubMed ID: 17011048
    [Abstract] [Full Text] [Related]

  • 18. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
    Berthelot L, Laplaud DA, Pettré S, Ballet C, Michel L, Hillion S, Braudeau C, Connan F, Lefrère F, Wiertlewski S, Guillet JG, Brouard S, Choppin J, Soulillou JP.
    Eur J Immunol; 2008 Jul 25; 38(7):1889-99. PubMed ID: 18506883
    [Abstract] [Full Text] [Related]

  • 19. Myelin basic protein-responsive blood T lymphocytes in patients with multiple sclerosis.
    Hashim GA, Brewen M.
    J Neurosci Res; 1985 Jul 25; 13(3):349-55. PubMed ID: 2580989
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.